PCRX Pacira Corp: Rentabilitas operasi

Logo perusahaan publik Pacira Corp (PCRX)

The EBIT margin reflects market expectations regarding the efficiency of Pacira BioSciences (PCRX). Strong physician confidence in Exparel and the ongoing fight against opioids strengthen the brand's position. The moderate use of external testers alongside in-house drug production optimizes costs, while the duplication of capacities by third-party plants eliminates shortages. The value of 4.20 determines this specific level of the operating profit parameter.

PCRX: Margin operasi Pacira Pharmaceuticals 04.07.2022 - 19.11.2026

Rincian metrik komprehensif lan analitis Pacira BioSciences (PCRX)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:PCRX, pacira.com
Produk dadi Pacira Corp

Operating margin measures the efficiency of profit generation from core business processes before accounting for debt service and taxes. This metric serves as a filter for stress-testing assets during periods of market volatility. By analyzing the operating margin chart, an investor determines the stability of operating cash flow. For Pacira BioSciences (PCRX), the stability of this indicator is supported by patent protection and the complexity of integrating drugs into hospital protocols. Such barriers limit competition, ensuring long-term pricing power.

Pesaing Pacira BioSciences

Rentabilitas operasi haleon.com|Rentabilitas operasi KVUE|Rentabilitas operasi Verona Pharma (VRNA)|Jyong Biotech (MENS) - Tingkat bathi adhedhasar bathi operasi|Margin operasi LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Rentabilitas operasi|PRGO - Rentabilitas operasi|Alvotech Corp (ALVO) - Margin dodolan operasi|LQDA: Margin operasi|Rentabilitas dodolan operasi glpg.com (GLPG)|Rentabilitas operasi ANI Pharmaceuticals Inc|MNKD: Tingkat bathi operasi|Margin dodolan operasi AMPH (Amphastar)|Margin operasi ARS Pharma (SPRY)|Theravance Biopharma - Margin dodolan operasi|Rasio bathi operasi AQST (Aquestive Therapeutics)|SCPH: Margin dodolan operasi|Rentabilitas dodolan operasi Tectonic Therapeutic|TNXP: Margin operasi|SXT China (SXTC) - Margin operasi|Rentabilitas operasi eupraxiapharma.com|BioHarvest Sciences (BHST) - Rentabilitas kegiatan operasi|Rentabilitas operasi Invizyne (EXOZ)|ORMP - Rentabilitas dodolan operasi|Margin operasi ENTX (Entera Bio)|Tingkat bathi adhedhasar bathi operasi MindWalk Therapeutics|ABVC: Margin dodolan operasi|CPIX - Margin operasi|QNTM (Quantum BioPharma) - Margin dodolan operasi|Margin bathi operasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Margin operasi|Margin operasi ranitherapeutics.com|Rentabilitas operasi Synergy CHC Corp. (SNYR)|Rallybio Corp - Rentabilitas dodolan miturut bathi operasi|lexariabioscience.com - Margin dodolan operasi|Margin operasi Pulmatrix Inc PULM|Pheton Holdings - Margin operasi|Margin bathi operasi APM|Lyra Therapeutics, Inc. (LYRA) - Rentabilitas operasi|Rentabilitas dodolan operasi Impact BioMedical, Inc. (IBO)|Rentabilitas operasi TNF Pharma|YCBD: Tingkat bathi operasi|Margin operasi PRFX|CYTO - Rentabilitas dodolan operasi|Rentabilitas operasi Lipella LIPO|Rasio bathi operasi OPTN (OptiNose, Inc.)|PIRS - Rentabilitas operasi|Procaps (PROC) - Margin dodolan operasi|PTPI: Margin operasi|Qilian International (QLI) - Margin operasi|Rentabilitas operasi Acelyrin, Inc.|Margin operasi TFF Pharmaceuticals, Inc.